iFyber

Surface-level clinical endpoints alone cannot capture the complete mechanism of action in advanced wound healing models. To build a robust regulatory package, sponsors must bridge macro-level data with quantitative micro-level metrics. Learn how integrating localized biomarker profiling and molecular microbiology into early-stage protocols isolates therapeutic efficacy from background physiological variance.

Wound care clinical trials are often evaluated using endpoints like wound size reduction, healing rate, or time to closure. These measurements rarely explain the biological mechanisms driving those outcomes. iFyber is hosting a webinar on June 24th to explore how to improve translational relevance in wound care studies. Register here: https://bit.ly/4uruvkE

Join Mariely M. for an exclusive webinar on the challenges shaping modern wound care studies. Mariely’s expertise spans biofilm models, antimicrobial evaluation, and clinically relevant microbiology systems. She’ll provide practical insight into improving study design and interpretation across wound care development programs. Register today: https://bit.ly/4uruvkE

Reliable wound care data depends on model selection, endpoint strategy, and reproducible testing conditions. Looking for more information on methods that support stronger interpretation across wound care clinical research? Join us for a free webinar on June 24th: https://bit.ly/4uruvkE

Wound care studies increasingly require clinically relevant models and quantitative microbiology endpoints. iFyber is hosting an exclusive webinar on June 24th where we’ll examine strategies for integrating lab analysis into study design and more. Register here: https://bit.ly/4uruvkE